Note: this post is the first in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management)...

Note: this post is the second in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management)...

Note: this post is the eighth in an eight-part series on data management strategies for personalized therapeutics, such as cell...

Note: this post is the seventh in an eight-part series on data management strategies for personalized therapeutics, such as cell...

Note: this post is the sixth in an eight-part series on data management strategies for personalized therapies, such as cell...

Note: this post is the fifth in an eight-part series on data management strategies for personalized therapies, such as cell...

Today, we announced Vineti’s $35 million Series C round of investment. A first-of-its-kind investor coalition of industry leaders — Cardinal Health,...